[177Lu]Lu-SSO110 with [68Ga]Ga-SSO120 companion imaging in patients with extensive-stage small-cell lung cancer (LuSato-1): a multicentre, phase 1, dose-escalation study
[177Lu]Lu-SSO110 with [68Ga]Ga-SSO120 companion imaging in patients with extensive-stage small-cell lung cancer (LuSato-1): a multicentre, phase 1, dose-escalation study. // The Lancet Medical Imaging & Theranostics. – URL: https://www.sciencedirect.com/science/article/pii/S3117452326000171?dgcid=rss_sd_all
[177Lu]Lu-SSO110 with [68Ga]Ga-SSO120 companion imaging in patients with extensive-stage small-cell lung cancer (LuSato-1): a multicentre, phase 1, dose-escalation study. The Lancet Medical Imaging & Theranostics. https://www.sciencedirect.com/science/article/pii/S3117452326000171?dgcid=rss_sd_all
“[177Lu]Lu-SSO110 with [68Ga]Ga-SSO120 companion imaging in patients with extensive-stage small-cell lung cancer (LuSato-1): a multicentre, phase 1, dose-escalation study.” The Lancet Medical Imaging & Theranostics.
@article{article68693,
title = {[177Lu]Lu-SSO110 with [68Ga]Ga-SSO120 companion imaging in patients with extensive-stage small-cell lung cancer (LuSato-1): a multicentre, phase 1, dose-escalation study},
journal = {The Lancet Medical Imaging \& Theranostics},
url = {https://www.sciencedirect.com/science/article/pii/S3117452326000171?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...